Envision® Surface Evaluation

This observational study will acquire initial clinical practice utilization and product safety data for the Envision® surface.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pressure Ulcer Skin Diseases Skin Ulcer Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Levindale Hebrew Geriatric Center and Hospital

Baltimore, Maryland, 21215, United States

About this study

This is a single site, open label, observational study to acquire initial clinical practice utilization information, product safety, and wound healing data, as defined by changes in wound volume and/or surface area, for patients with pressure ulcers placed on this surface.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject Weight < 400 lbs. Subject has Stage II, III, or IV pressure ulcer on weight bearing aspect of the body Subject estimated length of stay at least 7 days Subject Ability to provide informed consent

Exclusion criteria

Inability to provide informed consent

Treatment and study plan

Envision® Patient Support System

Device

Sponsors and collaborators

Lead sponsor

Hill-Rom

Industry

Registry information

Official study title

Envision® Surface Evaluation for Patients With Stage II, Stage III, or Stage IV Pressure Ulcers

Important dates

Study start: 2007
Study completion: 2008
First posted: Nov 30, 2006
Registry last updated: Jul 4, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed